维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

17篇 您的检索式：作者名="Thiolat"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	The mouse dendritic cell marker CD11 c is down-regulated upon cell activation through Toll-like receptor triggering显示文摘	Singh-Jasuja H Thiolat A Ribon M	2013	Immunobiology2013，218，1：	1
	2	Interleukin newcomers creating new numbers in rheumatology:IL-34 to IL-38显示文摘	Clavel G Thiolat A Boissier MC		0，，：	1
	3	Interleukin-35 gene therapy exacerbates experimental rheumatoid arthritis in mice显示文摘	Thiolat A Denys A Petit M	2014	Cytokine2014，69，1：	1
	4	Interleukin newcomers creating new numbers in rheumatology: IL-34 to IL-38显示文摘	Ga?lle Clavel Allan Thiolat Marie-Christophe Boissier	2013	Joint Bone Spine2013，，：	1
	5	Interleukin-35 gene therapy exacerbates experimental rheumatoid arthritis in mice 显示文摘	Thiolat A Denys AI Petit M	2014	Cytokine2014，69，1：	1
	6	Interleukin-35 gene therapy ex- acerbates experimental rheumatoid arthritis in mice 显示文摘	Thiolat A Denys A Petit M	2014	Cytokine2014，69，1：	1
	7	Interleukin-35 gene therapy exacerbates experimental rheumatoid arthritis in mice显示文摘	Thiolat A Denys A Petit M	2014	Cytokine2014，69，1：	1
	8	Interleukin newcomers cre- ating new numbers in rheumatology: 1L-34 to 1L-38显示文摘	Clavel G Thiolat A Boissier MC	2013	Joint Bone Spine2013，80，5：	1
	9	Interleukin-35 gene therapy exacerbates experimental rheumatoid arthritis in mice显示文摘	A. Thiolat A. Denys M. Petit J. Biton D. Lemeiter R. Herve D. Lutomski M.-C. Boissier N. Bessis	2014	Cytokine2014，，：	1
	10	Interleukin - 35 gene therapy exacerbates experimental rheumatoid arthritis in mice显示文摘	THIOLAT A DENYS A PETIT M	2014	Cytokine2014，69，1：	1
	11	Interleukin-35 gene therapy exacerbates experimental rheumatoid arthritis in mice显示文摘	Thiolat A Denys A Petit M	2014	Cytokine2014，69，1：	1
	12	Interleukin-35 gene therapy exacerbates experimental rheumatoid arthritis in mice显示文摘	Thiolat A Denys A Petit M	2014	Cytokine2014，69，1：	1
	13	In Vivo Expansion ofActivated Foxp3+ Regulatory T Cells and Establishment of a Type 2Immune Response upon IL-33 Treatment Protect against Experi-mental Arthritis显示文摘	Biton J Khaleghparast A than S Thiolat A	2016	J Immunol2016，197，5：	1
	14	Interleukin newcomers creating new numbers in rheumatology : IL-34 to IL-38 显示文摘	Clavel G Thiolat A Boissier MC	2013	Joint Bone Spine2013，80，5：	1
	15	Interleukin-35 gene therapy ex- acerbates experimental rheumatoid arthritis in mice 显示文摘	Thiolat A Denys A Petit M	2014	Cytokine2014，69，1：	1
	16	Intra-articular electrotransfer of mouse soluble tumour necrosis factor receptor in a murine model of rheumatoid arthritis显示文摘	Denys A Thiolat A Descamps D	2010	J Gene Med2010，12，8：	1
	17	Delayed and short course of rapamycin prevents organ rejection after allogeneic liver transplantation in rats显示文摘AIM To test whether a delayed and short course of rapamycin would induce immunosuppressive effects following allogeneic orthotopic liver transplantation(OLT) in rats.METHODS Allogeneic OLTs were performed using Dark Agoutilivers transplanted into Lewis recipients, and syngeneic OLTs were performed using the Lewis rat strain. Rapamycin(1 mg/kg per day) was administered by gavage from day 4 to day 11 post-transplantation. Lymphocyte cellular compartments were analyzed by flow cytometry in draining lymph nodes, non-draining lymph nodes and the spleen at days 11 and 42 in rapamycin-treated rats, untreated control rats and syngeneic grafted rats. Skin grafts from Dark agouti or from F344 RT were performed at day 30 on liver grafted rats treated with rapamycin.RESULTS An 8-d course of rapamycin treatment initiated 4 d following transplantation resulted in the survival of grafted rats for more than 100 d. In contrast, untreated rats died of liver failure within 13 to 21 d. The analysis of the cellular compartment revealed an increase in two cellular subpopulations, specifically myeloid-derived suppressor cells(MDSCs) and CD8+CD45RClow T cells, without major modifications in the regulatory T cell(Treg) compartment in treated rats in the early stages after grafting. We evaluated the ability of treated rats to reject third-party allogeneic skin grafts to confirm their immune competence. In contrast, when skin was collected from rats syngeneic to the grafted liver, it was not rejected.CONCLUSION Our results demonstrate that short and delayed rapamycin treatment allows for tolerance in allogeneic OLT. The results also allowed for the identification of the mechanisms of tolerance induced by rapamycin by identifying MDSCs and CD8+CD45RClow T cells as associated with the state of tolerance.	Salim Hamdani Allan Thiolat Sina Naserian Cynthia Grondin Stéphane Moutereau Anne Hulin Julien Calderaro Philippe Grimbert JoséLaurent Cohen Daniel Azoulay Caroline Pilon	2017	World Journal of Gastroenterology2017，23，38：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费